iJobs - an Internet Intervention for the Unemployed (iJobs)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05962554 |
Recruitment Status :
Recruiting
First Posted : July 27, 2023
Last Update Posted : May 10, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Unemployment | Behavioral: iJobs | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 180 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | The two independent groups (intervention vs. waiting list control group) will be crossed with three measurement times (i.e., baseline, post-intervention, and 1-month follow-up). Hence, the design will be a 2 (intervention vs. control) X 3 (baseline, post-intervention, and 1-month follow-up) factorial design. |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | iJobs - an Internet Intervention for the Unemployed: a Randomized Controlled Trial |
Actual Study Start Date : | June 6, 2023 |
Estimated Primary Completion Date : | June 28, 2024 |
Estimated Study Completion Date : | August 31, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Intervention group
The group that will be first randomly allocated to iJobs.
|
Behavioral: iJobs
iJobs is a 2-week intervention consisting of 5 modules focusing on discovering job skills, job search strategies, preparing effective resumes, exercising different types of interviews, and overcoming setbacks in the job search process. This is an adaptation of the JOBS program. |
Experimental: Waiting list control group
This group will receive the intervention 2-weeks after the intervention group finishes it.
|
Behavioral: iJobs
iJobs is a 2-week intervention consisting of 5 modules focusing on discovering job skills, job search strategies, preparing effective resumes, exercising different types of interviews, and overcoming setbacks in the job search process. This is an adaptation of the JOBS program. |
- Participants' self-efficacy regarding the job search process [ Time Frame: Change from baseline to post-intervention and follow-up (approximately 2 weeks and 6 weeks) ]The Job Search Self-Efficacy Scale (20-item) measures participants' perception of their ability to gain employment. The minimum score is 20 and the maximum is 100. A higher score means a better outcome (increased job search self-efficacy).
- Participants' job search intensity and effort [ Time Frame: Change from baseline to post-intervention and follow-up (approximately 2 weeks and 6 weeks) ]The investigators will use a version of Blau's Job-search behaviors scale adapted to the contemporary context and Romanian population. The scale measures participants' involvement in job search activities in terms of frequency and intensity. The minimum score is 16 and the maximum is 80. A higher score means a better outcome (increased job search behavior effort).
- The quality of participants' job search behaviors [ Time Frame: Change from baseline to post-intervention and follow-up (approximately 2 weeks and 6 weeks) ]The Job search quality scale has 20 items and measures the quality in which the job search behaviors are performed. The minimum score is 20 and the maximum is 100. A higher score means a better outcome (increased job search quality).
- Participants' ability to deal with setbacks in the job search process [ Time Frame: Change from baseline to post-intervention (approximately 2 weeks) ]Inoculation against setbacks (i.e., participants' ability to deal with setbacks) will be measured using 2 items retrieved from previous studies. The minimum score is 2 and the maximum is 10. A higher score means a better outcome (presence of inoculation against setbacks).
- Participants' overall self-esteem [ Time Frame: Change from baseline to post-intervention (approximately 2 weeks) ]Rosenberg's Self Esteem Scale measures global self-worth by measuring both positive and negative feelings about the self using 10 items. The minimum score of Rosenberg's Self Esteem Scale is 10 and the highest one is 40. A higher score means a better outcome.
- Participants' anxiety regarding their future career [ Time Frame: Change from baseline to post-intervention (approximately 2 weeks) ]The investigators will measure participants' anxiety regarding their future career with the Future Career Anxiety Scale. The minimum score is 5 and the maximum is 25. A higher score means a worse outcome (increased anxiety).
- Generalised Anxiety symptoms [ Time Frame: Change from baseline to post-intervention (approximately 2 weeks) ]The investigators will measure participants' anxiety symptoms using the Generalised Anxiety Disorder Assessment. This is a 7-item instrument that uses the DSM-V criteria to assess anxiety symptom severity. The minimum score is 0 and the highest one is 21. A higher score means a worse outcome (a higher level of anxiety).
- Depression symptoms [ Time Frame: Change from baseline to post-intervention (approximately 2 weeks) ]The investigators will measure participants' depression symptoms with the Patient Health Questionnaire-9. The scale measures participants' severity of depression using DSM IV criteria. The minimum score is 0 and the highest one is 27. A higher score means a worse outcome (more severe symptoms of depression).
- Participants' mental health complaints [ Time Frame: Change from baseline to post-intervention (approximately 2 weeks) ]The investigators will measure participants' mental health complaints with the Mental Health Complaints Scale. This is a 5-item instrument that will be used to assess mental health complaints. The minimum score is 6 and the highest is 30. A higher score means a worse outcome.
- Participants' psychological capital [ Time Frame: Change from baseline to post-intervention (approximately 2 weeks) ]The investigators will measure participants' psychological capital with the 12-item Compound PsyCap Scale. The minimum score is 12 and the highest is 72. A higher score means a better outcome.
- Physical health [ Time Frame: Baseline only ]The investigators will use a short version of Ware's Physical Health Complaints Scale to measure participants' perceptions of their health. The minimum score is 4 and the highest is 20. A higher score means a worse outcome (worse physical health).
- Treatment adherence [ Time Frame: Post-intervention only (approximately 2 weeks) ]Drop out rate; The number of completed assignments; Quality of completed assignment (qualitative rating of the degree of completeness and depth of the answer for each assignment, conducted by two independent experts based on apriori established coding grids).
- Satisfaction with the intervention [ Time Frame: Post-intervention only (approximately 2 weeks) ]Satisfaction with the intervention will be measured using 17 items. Eleven items are measured on a 4-points, 5-points, and 10-points Likert scale. Each item will be analyzed separately. A higher score means greater satisfaction. The other 6 items are open-ended questions and imply qualitative analysis.
- System usability [ Time Frame: Post-intervention only (approximately 2 weeks) ]We will use a 10-item questionnaire designed to measure participants' satisfaction with TalentLMS, the online platform used for the program delivery. The total score of System Usability Scale is 0 and the highest one is 100. A higher score means a better outcome.
- Sociodemographic information [ Time Frame: Baseline only ]Age, gender, residential area, educational level, average monthly income, unemployment period, work experience, and targeted professional field.
- Employment status [ Time Frame: Follow-up only (approximately 6 weeks) ]Self-reported employment status will be measured at follow-up, using a dichotomous question.
- Employment satisfaction [ Time Frame: Follow-up only (approximately 6 weeks) ]Self-reported employment quality will be measured at follow-up using 4 questions. One of them is a dichotomous question, while the other 3 questions are measured on a Likert scale. The minimum score is 3, and the maximum is 30. A higher score means greater satisfaction with the job.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Unemployed and looking for a job
- Work as volunteers and are looking for a paid job
- Have a PC or laptop and basic digital competencies
Exclusion Criteria:
- They don't have internet access and are not available during the two weeks of the program
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05962554
Contact: Andrei Rusu | 747174071 ext +40 | andrei.rusu@e-uvt.ro | |
Contact: Alexandra Bodnaru | alexandra.bodnaru@e-uvt.ro |
Romania | |
West University of Timisoara | Recruiting |
Timişoara, Romania, 300223 | |
Contact: Andrei Rusu |
Principal Investigator: | Andrei Rusu | West University of Timisoara |
Responsible Party: | West University of Timisoara |
ClinicalTrials.gov Identifier: | NCT05962554 |
Other Study ID Numbers: |
RCT iJobs |
First Posted: | July 27, 2023 Key Record Dates |
Last Update Posted: | May 10, 2024 |
Last Verified: | May 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
iJobs |